
Endovascular Today
@evtoday
Covering minimally invasive vascular disease therapies and providing the latest clinical data, commentaries, and regulatory news.
ID: 275690346
https://evtoday.com/subscribe 01-04-2011 20:04:26
6,6K Tweet
14,14K Followers
2,2K Following

Penumbra Commences STRIDE II Study of Lightning Bolt CAVT to Treat Lower Extremity ALI | Penumbra, Inc. evtoday.com/news/penumbra-…


Merit’s Wrapsody CIE Approved by Health Canada | Merit Medical evtoday.com/news/merits-wr…

Terumo Neuro’s Sofia 88 Support Catheter Launched in United States | Terumo Neuro evtoday.com/news/terumo-ne…


Drs. Meghan Clark (Meghan Clark, MD), Alexandra Banathy, & Nicole Keefe (Nikki Keefe), provide an overview of current strategies for managing type II endoleaks, illustrated by a case of persistent endoleak and sac enlargement after FEVAR. evtoday.com/articles/2025-…

Peter A. Soukas, MD (Peter Soukas, MD), and Pieter Storm de Klerk, MBChB, provide a case study on IVL for the treatment of calcified CAS demonstrating its technical feasibility and highlighting areas in need of further study. evtoday.com/articles/2025-…

Alex B. Chebl, MD (Alex B. Chebl), discusses a case that outlines a plan for endovascular management of acute ischemic stroke due to tandem occlusion. evtoday.com/articles/2025-…

Dr. vivian bishay discusses keys to a successful interventional radiology program, her role as National Co-Principal Investigator of SYMPHONY-PE, the broader clinical trial landscape for pulmonary embolism, and priorities for research in women’s health. evtoday.com/articles/2025-…




Merit Medical Acquires Biolife | Merit Medical evtoday.com/news/merit-med…

GE HealthCare CleaRecon DL for CBCT Imaging Launched in United States and Europe | GE HealthCare evtoday.com/news/ge-health…



Route 92 HiPoint 88 Reperfusion System Cleared by FDA | Route 92 Medical evtoday.com/news/route-92s…


Drs. Naseer Ahmad (Naseer Ahmad), Anahita Dua MD MS MBA FACS, Foluso Fakorede (PADADVOCATE; & his team), Carlos Mena, & Kim G. Smolderen, PhD discuss what does & doesn’t work for targeting those at risk for CLTI, common misconceptions for CLTI, & what research is needed. evtoday.com/articles/2025-…
